Overview

PET Imaging CCR2 in Lung Inflammation

Status:
Active, not recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the safety of the novel probe 64Cu-DOTA-ECL1i for PET imaging of CCR2 expression.
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine